» Articles » PMID: 26671213

Systematic Differences Between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis

Overview
Journal PLoS One
Date 2015 Dec 17
PMID 26671213
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Meta-analyses conducted via the Cochrane Collaboration adhere to strict methodological and reporting standards aiming to minimize bias, maximize transparency/reproducibility, and improve the accuracy of summarized data. Whether this results in differences in the results reported by meta-analyses on the same topic conducted outside the Cochrane Collaboration is an open question.

Methods: We conducted a matched-pair analysis with individual meta-analyses as the unit of analysis, comparing Cochrane and non-Cochrane reviews. Using meta-analyses from the cardiovascular literature, we identified pairs that matched on intervention and outcome. The pairs were contrasted in terms of how frequently results disagreed between the Cochrane and non-Cochrane reviews, whether effect sizes and statistical precision differed systematically, and how these differences related to the frequency of secondary citations of those reviews.

Results: Our search yielded 40 matched pairs of reviews. The two sets were similar in terms of which was first to publication, how many studies were included, and average sample sizes. The paired reviews included a total of 344 individual clinical trials: 111 (32.3%) studies were included only in a Cochrane review, 104 (30.2%) only in a non-Cochrane review, and 129 (37.5%) in both. Stated another way, 62.5% of studies were only included in one or the other meta-analytic literature. Overall, 37.5% of pairs had discrepant results. The most common involved shifts in the width of 95% confidence intervals that would yield a different statistical interpretation of the significance of results (7 pairs). Additionally, 20% differed in the direction of the summary effect size (5 pairs) or reported greater than a 2-fold difference in its magnitude (3 pairs). Non-Cochrane reviews reported significantly higher effect sizes (P< 0.001) and lower precision (P<0.001) than matched Cochrane reviews. Reviews reporting an effect size at least 2-fold greater than their matched pair were cited more frequently.

Conclusion: Though results between topic-matched Cochrane and non-Cochrane reviews were quite similar, discrepant results were frequent, and the overlap of included studies was surprisingly low. Non-Cochrane reviews report larger effect sizes with lower precision than Cochrane reviews, indicating systematic differences, likely reflective of methodology, between the two types of reviews that could generate different interpretations of the interventions under question.

Citing Articles

Interventions for people with perceptual disorders after stroke: the PIONEER scoping review, Cochrane systematic review and priority setting project.

Hazelton C, Todhunter-Brown A, Campbell P, Thomson K, Nicolson D, McGill K Health Technol Assess. 2024; 28(69):1-141.

PMID: 39485540 PMC: 11586814. DOI: 10.3310/WGJT3471.


Current trends, barriers, and facilitators of use of core outcome sets in Cochrane systematic reviews: Protocol.

Saldanha I, Hughes K, Dodd S, Lasserson T, Kirkham J, Lucas S F1000Res. 2024; 12:735.

PMID: 39399297 PMC: 11468176. DOI: 10.12688/f1000research.133688.2.


Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses - the METSA systematic review.

Gunge Riberholt C, Olsen M, Milan J, Haflidadottir S, Svanholm J, Pedersen E BMC Med Res Methodol. 2024; 24(1):196.

PMID: 39251912 PMC: 11382479. DOI: 10.1186/s12874-024-02318-y.


Accelerating evidence synthesis for safety assessment through ClinicalTrials.gov platform: a feasibility study.

Yu T, Yang X, Clark J, Lin L, Furuya-Kanamori L, Xu C BMC Med Res Methodol. 2024; 24(1):165.

PMID: 39080524 PMC: 11290241. DOI: 10.1186/s12874-024-02225-2.


Maintaining remission in Crohn's disease post surgery: what can we learn from Cochrane?.

Gordon M Frontline Gastroenterol. 2024; 15(3):241-246.

PMID: 38665790 PMC: 11042355. DOI: 10.1136/flgastro-2023-102559.


References
1.
Callaham M, Wears R, Weber E . Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA. 2002; 287(21):2847-50. DOI: 10.1001/jama.287.21.2847. View

2.
Ioannidis J . Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA. 1998; 279(4):281-6. DOI: 10.1001/jama.279.4.281. View

3.
Goodman S . Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med. 1999; 130(12):995-1004. DOI: 10.7326/0003-4819-130-12-199906150-00008. View

4.
Chan A, Altman D . Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ. 2005; 330(7494):753. PMC: 555875. DOI: 10.1136/bmj.38356.424606.8F. View

5.
Jorgensen A, Hilden J, Gotzsche P . Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ. 2006; 333(7572):782. PMC: 1602036. DOI: 10.1136/bmj.38973.444699.0B. View